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Abstract Substrates of most transport proteins have not been identified, limiting our
understanding of their role in physiology and disease. Traditional identification methods use
transport assays with radioactive compounds, but they are technically challenging and many
compounds are unavailable in radioactive form or are prohibitively expensive, precluding large-
scale trials. Here, we present a high-throughput screening method that can identify candidate
substrates from libraries of unlabeled compounds. The assay is based on the principle that
transport proteins recognize substrates through specific interactions, which lead to enhanced
stabilization of the transporter population in thermostability shift assays. Representatives of three
different transporter (super)families were tested, which differ in structure as well as transport and
ion coupling mechanisms. In each case, the substrates were identified correctly from a large set of
chemically related compounds, including stereo-isoforms. In some cases, stabilization by substrate
binding was enhanced further by ions, providing testable hypotheses on energy coupling
mechanisms.
DOI: https://doi.org/10.7554/eLife.38821.001
Introduction
Transport proteins, also called transporters, porters, carriers, translocases or permeases, encompass
a diverse and ubiquitous group of membrane proteins that facilitate the translocation of ions and
molecules across all types of biological membranes, linking biochemical pathways, maintaining
homeostasis and providing building blocks for growth and maintenance. They comprise 5–15% of
the genomic complement in most organisms. Transport proteins are classified into four major
groups: primary active transporters, secondary active transporters, facilitative transporters, and
channels. Human solute transport proteins have been divided into 65 subfamilies (based on
sequence alignments or experimentally determined substrate specificities), which transport a diverse
range of compounds, including amino acids, sugars, nucleotides, lipids, vitamins, hormones, inor-
ganic and organic ions, metals, xenobiotics and drugs (http://slc.bioparadigms.org/). Of the 538
identified solute transport proteins in humans, more than a quarter have no assigned substrate spec-
ificity (http://slc.bioparadigms.org/). Consequently, their role in human physiology is ill-defined and
opportunities for drug intervention are missed (Hediger et al., 2013). Currently, about half of the
transport proteins have been associated with human disease (Rask-Andersen et al., 2013;
Hediger et al., 2013; Lin et al., 2015), but only 12 classes of drugs target them directly, despite
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their inherent ‘druggability’ (Hediger et al., 2013; Lin et al., 2015; Ce´sar-Razquin et al., 2015;
Fauman et al., 2011). The situation is not better in other eukaryotic organisms and bacterial patho-
gens, currently on the WHO list (Supplementary file 1) (Elbourne et al., 2017). For most transport-
ers in the sequence databases, the identifications are preliminary because they are based only on
sequence homology without direct experimental evidence for the substrates, even though single
amino acid residue variations in the substrate binding site can alter the specificity profoundly. More-
over, the substrate specificities of some transporters may have been incompletely or incorrectly
assigned. Finally, there could be membrane proteins with unassigned function that belong to
unidentified transporter families, which are not counted at all.
One of the major challenges is to find the correct substrates from a large number of potential
candidates. There are approximately ~3,000 metabolites in Escherichia coli (Sajed et al.,
2016), ~16,000 in Saccharomyces cerevisiae (Ramirez-Gaona et al., 2017), ~40,000 in Homo sapiens
(Wishart et al., 2013), and plants must have even more as they carry out an extensive secondary
metabolism. Some metabolites, such as vitamin B6, have several interconvertible species, each of
which could be transported. The classical method to identify transport proteins monitors the accu-
mulation of radiolabeled compounds in whole cells, membrane vesicles or proteoliposomes. How-
ever, these experiments can easily fail when the expressed transporters are not active due to
targeting, insertion or folding issues, when they are unstable in purification and reconstitution
experiments, or when substrate and coupling ion gradients are not setup correctly. Moreover, some
compounds are not available in radioactive form or are prohibitively expensive, preventing large-
scale identification trials. Given all these technical difficulties, it is often necessary to limit the number
of candidate substrates first by using phylogenetic analysis, by analyzing phenotypic (patho)physio-
logical data, by complementation studies or by metabolic analysis of knock-out or mutant strains.
Therefore, there is an unmet demand for the development of new methods to limit the number
of potential substrates for identification of solute carriers. Here, we present a high-throughput
screening method for the identification of substrates of transporters, which does not require radioac-
tive compounds or prior knowledge. The method uses the simple concept that transporters recog-
nize their substrates through specific interactions, enhancing their stabilization in thermostability
shift assays. We verify the approach by defining the substrate specificity of three solute carriers from
different bacterial and eukaryotic protein families and show that these experiments also provide
valuable clues about the ion coupling mechanism.
Results
Principle of the method
Ligands, such as substrates or inhibitors, are recognized by transport proteins through specific inter-
actions at the exclusion of other molecules. The formation of these additional bonds leads to an
increase in the total number of interactions (Robinson and Kunji, 2006; Yan, 2017;
Yamashita et al., 2005). Consequently, binding leads to an overall increase in the stability of the
ligand-bound species compared to the unliganded species in the population of protein molecules.
We have previously shown that the mitochondrial ADP/ATP carrier (AAC) from the thermophilic fun-
gus Thermothelomyces thermophila (UniProt G2QNH0) when purified in dodecyl-maltoside is stabi-
lized upon binding of its specific inhibitors carboxyatractyloside and bongkrekic acid in
thermostability shift assays using the thiol-reactive fluorophore N-[4-(7-diethylamino-4-methyl-3-cou-
marinyl)-phenyl]-maleimide (CPM) (Crichton et al., 2015; King et al., 2016). In the assay, the appar-
ent melting temperature Tm of a population of purified transporters is determined by monitoring
the increase in fluorescence by CPM reacting with thiols that have become exposed due to thermal
denaturation of the proteins (Figure 1a). The apparent melting temperature Tm is the temperature
at which the rate of unfolding for a given population is highest. We tested whether transported sub-
strates can also cause a shift in thermostability, as their properties differ quite substantially from
those of inhibitors or other tight binders. Indeed, the thermostability of the AAC population was
enhanced in the presence of ADP and ATP, but not in the presence of AMP, which reflects the
known substrate specificity of the carrier well (Mifsud et al., 2013) (Figure 1b). This effect is only
observed at high concentrations of the substrate, well above the apparent Km of transport (Fig-
ure 1—figure supplement 1). The higher the substrate concentration, the higher the likelihood that
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Figure 1. Substrate-induced stabilization of a mitochondrial ADP/ATP carrier. (a) As protein molecules in a
population unfold due to a gradual rise in temperature (25–90˚C), buried cysteine residues become solvent-
exposed and accessible to the thiol-specific probe CPM (blue stick representation) that becomes fluorescent upon
reaction. (b) Typical unfolding curves of the mitochondrial ADP/ATP carrier of Thermothelomyces thermophila (2
mg) in the absence and presence of 2.5 mM AMP, ADP and ATP, shown in red, blue and green, respectively. (c)
The apparent melting temperature (Tm) is the peak in the derivative of the unfolding curve (dF/dT), which is used
as an indicator of thermal stability. The apparent melting temperatures reported in the text are from three
independent protein purifications.
DOI: https://doi.org/10.7554/eLife.38821.002
The following figure supplement is available for figure 1:
Figure supplement 1. Substrate-induced stabilization of a mitochondrial ADP/ATP carrier.
DOI: https://doi.org/10.7554/eLife.38821.003
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part of the population is prevented from unfolding by binding of the substrate, leading to the
observed shift in thermostability. We reasoned that this approach could be applied as a screening
method to find substrate candidates of uncharacterized transporters by using compound libraries.
To verify the method, we have tested transporters from three different (super)families, which are dis-
tinct in structure and transport mechanism.
Substrates cause specific thermostability shifts in different transporters
The galactose transporter GalP of E. coli (Henderson, 1977) is a prototypical member of the sugar
porter family that belongs to the major facilitator superfamily (MFS) (Pao et al., 1998). Currently,
the MFS contains 24 different transporter families and 320,665 sequence entries from 5224 species,
but the substrates for the vast majority of them have not been formally identified (Pfam CL0015). In
humans, 14 of the 65 solute carrier families belong to the MFS, and substrates are not known for
around 12% of them (http://slc.bioparadigms.org/).
The structure of GalP has not been determined, but those of its mammalian homologs GLUT1
(Deng et al., 2014), GLUT3 (Deng et al., 2015), and GLUT5 (Nomura et al., 2015) are available
(Figure 2a). GalP contains three cysteine residues, of which only one is readily accessible to reaction
with N-ethylmaleimide (McDonald and Henderson, 2001). To evaluate the strategy, we measured
the unfolding curves of purified GalP in dodecyl-maltoside in the presence of a large number of dif-
ferent sugars. We determined the temperature shift by subtracting the apparent Tm of unliganded
GalP (57.6 ± 0.3˚C) from the apparent Tm values observed in the presence of compounds (DTm).
The GalP population was markedly stabilized by D-glucosamine (DTm; 5.7 ± 0.4˚C), D-glucose (DTm;
4.2 ± 0.5˚C), D-galactose (DTm; 2.1 ± 0.6˚C) (Figure 2—figure supplement 1), and to a lesser extent
by D-talose, 2-deoxy-D-glucose, 6-deoxy-D-glucose. Importantly, the related L-isoforms showed no
significant shift (Figure 2b). These results match the known substrate specificity of GalP well
(Henderson and Maiden, 1990; Walmsley et al., 1994). D-Glucosamine, the most stabilizing com-
pound, had not been investigated previously, but transport assays showed that this compound is a
new substrate (Figure 2—figure supplement 2), demonstrating that the assay can be used to dis-
cover as well as to extend the substrate specificity of transport proteins.
The transport protein Mhp1 from Microbacterium liquefaciens (Uniprot D6R8X8) transports 5-
substituted hydantoins in a sodium-coupled mechanism (Suzuki and Henderson, 2006;
Shimamura et al., 2010) (Figure 2c), and is a member of the nucleobase-cation-symport family of
homologous proteins that also transport purines, pyrimidines, vitamins and related metabolites. The
transporter has the LeuT-fold (Shimamura et al., 2010; Yamashita et al., 2005) and belongs to the
amino acid-polyamine-organocation superfamily (Va¨stermark and Saier, 2014), which currently con-
tains 20 families and 147,819 sequence entries, the substrates of which have mostly not been identi-
fied (Pfam CL0062). Mhp1 contains three cysteine residues, of which only one is readily accessible to
reaction with N-ethylmaleimide (Calabrese et al., 2017). Purified Mhp1 in dodecyl-maltoside had an
apparent Tm of 51.3˚C ± 0.6˚C and to test the binding specificity, the DTm was determined upon
addition of different nucleobases and other compounds (Figure 2d). The only stabilizing compounds
were 5-indolylmethyl-L-hydantoin (DTm; 14.1 ± 1.2˚C), 5-benzyl-L-hydantoin (DTm; 13.6 ± 1.2˚C) and
5-bromovinylhydantoin (DTm; 11.9 ± 1.1˚C) (Figure 2—figure supplement 3). A chemically related
inhibitor of Mhp1, 5-(2-naphthylmethyl)-L-hydantoin (L-NMH) also led to a thermostability shift (DTm;
15.6 ± 1.7˚C) (Figure 2d). These results match the known substrate and inhibitor specificity of Mhp1
(Simmons et al., 2014), showing that the assay could identify substrates from a set of closely related
compounds without false positives.
To validate the method further, we also screened the mitochondrial ADP/ATP carrier from T. ther-
mophila (UniProt G2QNH0) (King et al., 2016) (Figure 2e). This transport protein belongs to the
mitochondrial carrier family (MCF), which is involved in the translocation of chemically diverse com-
pounds across the mitochondrial inner membrane, using uniport, symport or antiport modes of
transport (Kunji, 2012). Currently, there are 89,340 different sequence entries from 831 different
species in the database (Pfam PF00153). In humans, the MCF is the largest solute carrier family with
53 different members (SLC25), but the substrate specificity of only half of them has been defined
(Kunji, 2012). We screened the thermostability of purified AAC using a library of mitochondrial com-
pounds (Figure 2—figure supplement 4). In the presence of ATP, ADP, and dADP the population
was stabilized, showing DTm values of 7.2 ± 0.2, 6.0 ± 0.5 and 1.8 ± 0.2˚C, respectively (Figures 1b
and 2f). Some other compounds, mostly structurally related nucleotides, also stabilized the protein,
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Figure 2. Validation of the method for determining substrate specificity using three unrelated proteins. (a), (c) and (e) Structural models of GalP (based
on GLUT5, PDB 4YBQ), Mhp1 (PDB 2JLN) and AAC (based on Aac2p, PDB 4C9G), respectively. The models are shown in rainbow cartoon and wheat
surface representations. Cysteine residues are shown as spheres, except for Cys-19 of GalP, which could not be modeled. (b), (d) and (f) Thermostability
screen of GalP (3 mg), Mhp1 (3 mg) and AAC (2 mg) against sugar (50 mM final concentration), nucleobase (2 mM) and nucleotide libraries (2.5 mM),
respectively. The temperature shift (DTm) is the apparent melting temperature in the presence of compound minus the apparent melting temperature
in the absence of compound. The data are represented by the standard deviation of five, three and three independent repeats, respectively. Two-tailed
Student’s t-tests assuming unequal variances were performed for the significance analysis (0.05 < p-value: not significant; 0.01 < p-value<0.05: *;
0.001 < p-value<0.01: **; 0.0001 < p-value<0.001: ***; p-value<0.0001: ****). L-BH, 5-benzyl-L-hydantoin; BVH, 5-bromovinylhydantoin; L-IMH, 5-
indolylmethyl-L-hydantoin, L-NMH 5- (2-naphthylmethyl)-L-hydantoin.
DOI: https://doi.org/10.7554/eLife.38821.004
The following figure supplements are available for figure 2:
Figure supplement 1. Substrate-induced stabilization of the galactose transporter GalP.
DOI: https://doi.org/10.7554/eLife.38821.005
Figure supplement 2. Glucosamine is a transported substrate of the galactose transporter GalP.
DOI: https://doi.org/10.7554/eLife.38821.006
Figure supplement 3. Ligand-induced stabilization of Mhp1 in the presence of sodium ions.
DOI: https://doi.org/10.7554/eLife.38821.007
Figure supplement 4. Substrate screening of the mitochondrial ADP/ATP carrier.
DOI: https://doi.org/10.7554/eLife.38821.008
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but with significantly smaller shifts (Figure 2f). For each type of nucleotide, the di- and tri-phosphate
species showed larger shifts than the monophosphate forms, similar to the preference of ATP and
ADP over AMP (Figures 1d and 2f), showing that the assay can also identify functional groups that
are important contributors to substrate binding.
Substrate screening of a mitochondrial carrier from Tetrahymena
thermophila
To see whether this method can be used to identify candidate substrates for a previously uncharac-
terized transporter, we performed a high-throughput screen on a purified mitochondrial carrier from
the thermophilic ciliate Tetrahymena thermophila (UniProt I7M3J0). The carrier is phylogenetically
related to the yeast mitochondrial carrier that transports inorganic phosphate in symport with a pro-
ton into the mitochondrial matrix for ATP synthesis (Runswick et al., 1987), but its substrates have
not been identified experimentally. The population of carriers had an apparent Tm of 56.0 ± 0.8˚C
and was screened against a library of 132 different mitochondrial compounds at pH 6.0 (Figure 3).
The highest shift in the Tm of the population was observed for phosphate (DTm; 4.6 ± 0.4˚C), fol-
lowed by glyoxylate (DTm; 3.6 ± 0.8˚C), acetyl-phosphate (DTm; 3.2 ± 0.5˚C) and phosphoenolpyr-
uvate (DTm; 2.3 ± 0.2˚C) (Figure 3—figure supplement 1), whereas small shifts were observed for
nucleotides. These compounds either contain phosphate as a functional group or resemble the struc-
ture of phosphate, such as glyoxylate (Figure 3—figure supplement 2). Thus, this assay can be used
to narrow down substantially the number of potential substrate candidates from a library of unla-
beled compounds. Uptake assays using protein reconstituted into proteoliposomes confirmed that
the mitochondrial carrier exchanges phosphate (Figure 3—figure supplement 3a). We also tested
whether glyoxylate, phosphoenolpyruvate and acetyl phosphate, which also gave a shift in thermo-
stability assays, were transported, but none of them did (Figure 3—figure supplement 3b). How-
ever, in competition assays glyoxylate abolished uptake, demonstrating that it competes effectively
with [33P]-orthophosphate for binding when present in a 1000-fold excess (Figure 3—figure supple-
ment 3c).
The effect of coupling ions
Secondary active transporters are widespread and often use the electrochemical gradient of protons
or other ions to drive the uptake of substrates against their concentration gradient. Coupling ions
are also recognized by transporters through specific interactions, often directly associated with the
binding of substrates (Kunji and Robinson, 2010; Krishnamurthy et al., 2009).
5-Benzyl-L-hydantoin is transported by Mhp1 in symport with sodium ions (Suzuki and Hender-
son, 2006; Shimamura et al., 2010) and thus, we tested whether the temperature shifts of Mhp1
induced by substrate binding were ion-dependent. When different ions were tested, only sodium
ions induced a large substrate stabilization, whereas relatively small stabilizations were observed in
the presence of potassium, calcium and magnesium ions (Figure 4a).
Mitochondrial phosphate carriers are proton-driven, coupling phosphate translocation to proton
symport (Kunji and Robinson, 2010). To investigate whether proton-dependency of substrate bind-
ing could be inferred from the assay, the shift in thermal stability by substrate binding was deter-
mined at pH 6.0 and 8.0. The pH can affect the reaction of maleimide groups of CPM with free
thiols and the stability of the protein itself, but the DTm value shows the effect of pH on substrate
binding only. In both cases, a substrate-induced stabilization was observed, but the effect was larger
in pH 6.0 than in pH 8.0 (DTm 4.6 ± 0.4˚C and 2.6 ± 0.4˚C, respectively) (Figure 4b).
As a control, we carried out the same experiment with the mitochondrial ADP/ATP carrier, which
is not a proton symporter (Figure 4c). The opposite effect was observed; substrate binding at pH
8.0 led to a bigger thermostability shift than at pH 6.0. The predicted substrate-binding site of AAC
has three positively charged residues that interact with the negatively charged phosphate groups of
ADP and ATP (Kunji and Robinson, 2006; Robinson and Kunji, 2006). ATP has pKa values of 0.9,
1.5, 2.3 and 7.7, whereas ADP has pKa values 0.9, 2.8 and 6.8. This means that the substrates are
more negatively charged at pH 8.0 compared to pH 6.0, which will enhance their binding to the pos-
itively charged residues of the substrate binding site, leading to an increase in thermostability. In the
case of the phosphate carrier, the situation is very different. Phosphate has pKa values of 2.2, 7.2
and 12.3, and the predicted binding site contains two positively charged residues to neutralize the
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Figure 3. Identification of substrates for a mitochondrial phosphate carrier from the thermophilic ciliate Tetrahymena thermophila. Purified carrier (1 mg)
in lauryl maltose neopentyl glycol was incubated at pH 6.0 with 2.5 mM of each library compound separately and the DTm was determined, which is the
difference between the apparent melting temperatures in the presence and absence of the tested compound. The data are represented by the
average and standard deviation of three independent assays. The significance tests were performed as described in the legend to Figure 2.
Figure 3 continued on next page
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two negative charges on phosphate. However, in addition, the binding site contains a negatively
charged glutamate, which has a pKa of ~4.0. The coupling proton mediates bonding of the substrate
and the carboxyl group of the glutamate residue (Kunji and Robinson, 2010), which occurs more
readily at pH 6.0 than pH 8.0, explaining the difference in thermostability. In support of this notion
the transport rates of the phosphate carrier are high at pH 6.0 and virtually absent at pH 8.0
(Stappen and Kra¨mer, 1994). These results show that substrate binding stabilizes the transporters,
but that this effect is enhanced further by the presence of coupling ions, providing testable hypothe-
ses on energy coupling mechanisms.
Figure 3 continued
DOI: https://doi.org/10.7554/eLife.38821.009
The following figure supplements are available for figure 3:
Figure supplement 1. Substrate-induced stabilization of the mitochondrial phosphate carrier.
DOI: https://doi.org/10.7554/eLife.38821.010
Figure supplement 2. Chemical structures of compounds that showed significant thermostability shifts with the mitochondrial phosphate carrier.
DOI: https://doi.org/10.7554/eLife.38821.011
Figure supplement 3. Phosphate is transported by the putative phosphate carrier of Tetrahymena thermophila.
DOI: https://doi.org/10.7554/eLife.38821.012
Figure 4. The effect of coupling ions on the stabilization of transporters by substrate binding. (a) Thermostability
shifts of Mhp1 (3 mg) induced by binding of hydantoins in the presence of 140 mM NaCl, KCl, CaCl2 and MgCl2.
L-BH: 5-benzyl-L-hydantoin, BVH: 5-bromovinylhydantoin, L-IMH: 5-indolmethyl-L-hydantoin. (b) Thermostability
shifts of the phosphate carrier (1 mg) induced by binding of 2.5 mM phosphate-containing compounds at pH 6.0
and 8.0. Acetyl-Pi: acetyl-phosphate, Pi: phosphate. (c) Thermostability shifts of the (2 mg) induced by 2.5 mM ADP
and ATP binding at pH 6.0 and 8.0, using AMP as control.
DOI: https://doi.org/10.7554/eLife.38821.013
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Discussion
We have shown that thermostability assays can be used to study the interaction of substrates with
transporters, which is not intuitive, as substrates only bind transiently. Still, for diverse types of trans-
port proteins, which differ in structure and transport mechanism, a shift in thermostability was
observed in the presence of specific substrates. The shift is observed at concentrations well above
the apparent Km of transport, as under these conditions a larger part of the protein population is
rescued from unfolding by binding of the substrate, increasing the overall number of interactions.
These studies highlight the different contributions that these assays can make to studying the
properties of transport proteins. First, they can be used to limit the number of potential substrate
candidates from libraries of unlabeled compounds, providing important clues about the substrate
specificity (Figures 2 and 3). In the tested cases, the assay correctly identified the substrates from a
set of chemically related compounds, including stereo-isoforms. Still, these candidates need to be
tested by transport or other types of assays, as the compounds could potentially be inhibitors, com-
petitors or regulators. However, no prior knowledge is required and the number of radioactive com-
pounds that need testing is highly reduced, meaning that it is easier and cheaper to establish a
robust transport assay. Second, the assays can be used to extend the substrate specificity of known
transport proteins, as was shown for GalP with D-glucosamine (Figure 2b). Third, they can be used
to identify functional groups that are key to substrate binding, as shown for AAC, where nucleotide
di- and tri-phosphates bound more tightly than nucleotide monophosphates (Figure 2f). In the case
of mitochondrial phosphate carriers, the common properties of compounds, such as the phosphate
group, may lead directly to the most probable candidates. Fourth, this assay can provide important
clues on the involvement of coupling ions in substrate binding, as shown for cases where transport is
driven by sodium ion or proton symport (Figure 4).
This method has major advantages over the traditional methods of identification. It is highly
reproducible and can be performed in a high-throughput manner, allowing screening of about 100
compounds per machine per hour. The assay requires a relatively small amount of protein per assay
(micrograms), depending on the number of buried cysteine residues. Another advantage is that the
unfolding curves are themselves important quality checks, as they indicate that the protein is folded
and therefore competent to bind substrate. Compounds which are poorly soluble in water can be
added dissolved in dimethyl sulfoxide, provided that the final concentration of the solvent is kept
low. Another advantage is that most compounds of the library can be used as internal controls, pro-
viding a reliable discrimination between positive and negative results. Furthermore, generic stabiliz-
ing and destabilizing compounds can be identified as more proteins of the same family are tested.
For example, the polyamines spermine and spermidine have a destabilising effect on all purified
mitochondrial carriers tested in our laboratory with the exception of AAC. These observations will
reduce false positives for members of the same protein family. We have also observed that proteins
incorporated into nanodiscs or amphipols can be successfully assayed using this approach, which is
potentially useful for membrane proteins that are unstable in detergents.
There are also some limitations, as only proteins that have buried thiols can be used, although
accessible cysteines can be tolerated as they only raise the base line of the assay without interfering
with the unfolding curve. Thiol-containing compounds, such as cysteine or glutathione, cannot be
screened as the probe reacts with them directly. However, changes in the fluorescence of
environmentally sensitive dyes or endogenous tryptophans can be used as alternatives to CPM. Fur-
thermore, the assay requires purified and stable transporter in detergent, although partially purified
protein might be sufficient. Advances in bacterial (King et al., 2016; Ward et al., 1999), yeast
(Routledge et al., 2016), insect (Contreras-Go´mez et al., 2014), and mammalian (Goehring et al.,
2014; Andre´ll and Tate, 2013) expression systems have allowed many transporters to be expressed
in folded and functional states. Also, robust purification methods and novel classes of ‘stabilizing’
detergents, such as the neopentyl glycol maltoside detergents (Chae et al., 2010), have allowed
even poorly expressed transporters to be purified in the small quantities required for these studies.
Even though the main purpose of this study was to identify potential substrates of transporters,
the assays may also be used in drug discovery or in the identification of substrates, inhibitors and
regulators of any other soluble or membrane proteins with occluded cysteines.
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Materials and methods
Key resources table
Reagent type
(species) or resource Designation Source or reference Identifiers Additional information
Chemical
compound, drug
Dodecyl-b-D-maltoside Glycon Biochemicals
GmbH
Glycon:D97002
Chemical
compound, drug
Dodecyl maltose
neopentyl glycol
Anatrace Anatrace:NG310
Chemical
compound, drug
N-[4-(7-diethylamino-4-methyl-3-
coumarinyl)phenyl]
maleimide (CPM)
Sigma Sigma:C1484
Chemical
compound, drug
Complete Mini EDTA-free
protease inhibitor tablets
Roche Roche:5056489001
Chemical
compound, drug
Nickel Sepharose
(High Performance)
GE Healthcare GE Healthcare:17526802
Chemical
compound, drug
Nickel-NTA Superflow Qiagen Qiagen:30430
Chemical
compound, drug
Factor Xa protease NEB NEB:P8010L
Chemical
compound, drug
Tetraoleoyl cardiolipin (TOCL) Avanti Polar Lipids Avanti Polar
Lipids:710335C
Chemical
compound, drug
E. coli polar lipid extract Avanti Polar Lipids Avanti Polar
Lipids:100600C
Chemical
compound, drug
[14C]-galactose American Radiolabeled
Chemicals
American Radiolabeled
Chemicals:ARC0117
Chemical
compound, drug
[14C]-glucosamine American Radiolabeled
Chemicals
American Radiolabeled
Chemicals:ARC0118A
Chemical
compound, drug
[33P]-orthophosphate Hartmann Analytic Hartmann Analytic:FF-01
Chemical
compound, drug
BioBeads BioRad BioRad:152–3920
Chemical
compound, drug
C10E5 Sigma Sigma:76436
Chemical
compound, drug
Hydantoin compounds Other A gift from Marta Sans,
Maria Kokkinidou and
Arwen Pearson,
University of Hamburg
Software,
algorithm
Prism GraphPad
Strain, strain
background
(S. cerevisiae)
Saccharomyces
cerevisiae W303-1B
ATCC ATTC:201238
Strain, strain
background
(S. cerevisiae)
Saccharomyces
cerevisiae WB12
PMID:9878703 A gift from Dr H. Terada,
Tokyo University of Science
Strain, strain
background (E. coli)
Escherichia coli JM1100 PMID:15558
Recombinant
DNA reagent
Modified pYES3 vector PMID:26453935
An additional key resources table is presented in Supplementary file 2, and details the compounds
in the libraries.
Materials
Chemicals were obtained from Sigma Aldrich and Thermo Fisher Scientific (USA). Nickel NTA and
sepharose beads were purchased from Qiagen (USA). All enzymes were provided by New England
BioLabs (USA). Lipids were purchased from Avanti Polar Lipids (USA) and detergents from Anatrace
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(USA). The hydantoin compounds were a kind gift of Marta Sans, Maria Kokkinidou and Arwen Pear-
son (University of Hamburg).
Protein expression
For expression of mitochondrial ADP/ATP carrier of Thermothelomyces thermophila and the puta-
tive phosphate carrier of Tetrahymena thermophila in yeast mitochondria, gene constructs were
designed to contain an N-terminal tag composed of eight histidine residues followed by a Thr-Ser-
Glu-Asp linker and an Ile-Glu-Gly-Arg Factor Xa protease cleavage site. The genes were cloned into
pYES3/CT vector (Invitrogen, USA) with a constitutively active promoter (pMIR promoter of the S.
cerevisiae phosphate carrier). The plasmids were transformed into S. cerevisiae WB.12 (MATa ade2-
1 trp1-1 ura3-1 can1-100 aac1::LEU2 aac2::HIS3) and W303-1B (MATa leu2-3,112 trp1-1 can1-100
ura3-1 ade2-1 his3-11,15) strains, respectively. Cells were grown in a 50-l fermenter after which mito-
chondria were prepared (Kunji and Harding, 2003).
For expression of GalP in E. coli the promoter region and the galP gene, which was modified to
encode six histidine residues at the C-terminus of the protein, were cloned into plasmid pBR322 to
form plasmid pGP1, which was transformed into the galactose/glucose transport-deficient host strain
JM1100 (ptsG ptsM ptsF mgl galP Hfr Dhis gnd thyA galK) (Henderson et al., 1977). Cells were
grown in basal salts medium supplemented with 30 mM glycerol, 20 mg/ml thymine, 80 mg/ml histi-
dine and 15 mg/ml tetracycline in a fermenter (30- or 100-liter scale). The gene hyuP from M. liquefa-
ciens, modified to encode six histidine residues at the C-terminus, was cloned into plasmid pTTQ18
(Stark, 1987; Suzuki and Henderson, 2006). The His6-tagged Mhp1 hydantoin transport protein
was expressed in E. coli BL21 (DE3) grown in M9 medium supplemented with 20 mM glycerol, 20
mM NH4Cl, 100 mg/ml of carbenicillin, 0.2% w/v casamino acids, 2 mM MgSO4.7H2O, 0.4 mM
CaCl2.2H2O, using induction by IPTG in 100-l fermenter cultures. In all cases after harvesting the
intact cells preparations were made of inner membranes (Ward et al., 1999), which were stored at
 80˚C in Tris-HCl buffer pH 7.5 until used for purification of each individual protein.
Protein purification
The mitochondrial ADP/ATP carrier and phosphate carrier were purified using the detergents
dodecyl-maltoside and lauryl maltose neopentyl glycol, respectively, using established procedures
(King et al., 2016).
For the purification of His-tagged GalP, E. coli membranes were solubilized in buffer containing
20 mM Tris-HCl pH 8, 20 mM imidazole, 300 mM NaCl, 20% glycerol and 1% dodecyl-maltoside for
1 hr at 4˚C with gentle mixing to a final protein concentration of 2.5 mg/ml. After centrifugation
(108,000 x g, 1 hr, 4˚C), the supernatant was mixed with pre-washed nickel-NTA resin and purified
by immobilized nickel affinity chromatography (1 ml resin per 37 mg of total protein; Superflow, Qia-
gen) for batch-binding affinity chromatography for 1 hr at 4˚C. Non-specific proteins were removed
with buffer containing 20 mM Tris-HCl pH 8, 20 mM imidazole, 150 mM NaCl, 10% glycerol and
0.02% dodecyl-maltoside, after which His-tagged GalP was eluted with buffer containing 20 mM
Tris-HCl pH 8, 200 mM imidazole, 100 mM NaCl, 5% glycerol and 0.02% dodecyl-maltoside. Imidaz-
ole was then removed by passing the sample through pre-equilibrated PD-10 desalting column (GE
Healthcare). Protein samples were snap-frozen and stored in liquid nitrogen.
The purification of Mhp1 followed the same procedure as the GalP purification with the following
modifications. Membranes were solubilized for 2 hr and incubated with Nickel NTA resin for 2 hr.
The wash buffer contained 10 mM Tris-HCl pH 8, 20 mM imidazole, 10% glycerol and 0.05%
dodecyl-maltoside and the elution buffer contained 10 mM Tris-HCl pH 8, 200 mM imidazole, 2.5%
glycerol and 0.05% dodecyl-maltoside.
Reconstitution
Twelve milligrams of total polar lipid extract (Avanti Polar Lipids, Alabaster) was dried under a
stream of nitrogen, washed with methanol, and dried as before. Lipids were re-hydrated in 20 mM
MES pH 6.5, 50 mM NaCl and, when required, compound was added to a final concentration of 20
mM from a 200 mM stock. Lipids were solubilised by vortexing in the presence of 1.5% (v/v) penta-
ethylene glycol monodecyl ether, and 50 mg protein was added. The samples were incubated on ice
for 5 min, and pentaethylene glycol monodecyl was removed to form liposomes by addition of bio-
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beads (Bio-Rad, Hemel Hempstead, UK). Eight additions of bio-beads were made to the sample: the
first four used 60 mg, and the final four used 120 mg. Between additions, the samples were incu-
bated with inversion at 4˚C for 20 min. Following the final bio-bead addition, the samples were incu-
bated overnight at 4˚C with inversion. Bio-beads were removed by passage of the sample through
empty micro-bio spin columns (Bio-Rad, Hemel Hempstead, UK). The external buffer was replaced
with 20 mM MES pH 6.5, 50 mM NaCl using a PD10 desalting column (GE Healthcare, Little Chal-
font, UK). When required, competitors were added externally to a final concentration of 20 mM.
Transport assays
Robotic transport assays were performed using a Hamilton MicroLab Star robot (Hamilton Robotics
Ltd, UK). For GalP transport assays, E. coli cells (GalP-expressing strain pGP1/JM1100 and JM1100
control strains) were diluted to OD600 of 20 in MES buffer (5 mM MES pH 6.6, 150 mM KCl) and
incubated at room temperature with 20 mM glycerol for 10 min to be energized prior to being
loaded into the wells of a MultiScreenHTS +Hi Flow-FB (pore size = 1.0 mm, Millipore). Transport
assays were initiated by addition of 100 ml of buffer containing 5 mM [14C]-galactose (American
Radiolabeled Chemicals, 0.2 GBq/mmol) or 5 mM [14C]-glucosamine (American Radiolabeled Chemi-
cals, 0.2 GBq/mmol). For the competition assay, radiolabeled substrate was mixed with a 4000-fold
excess of the competitor compound prior to the assay. For phosphate transport assays, 100 ml pro-
teoliposomes were loaded into a MultiScreenHTS-HA 96-well filter plate (pore size, 0.45 mm; Milli-
pore, Billerica), and transport was initiated by the addition of 100 ml of buffer containing 20 mM
[33P]-orthophosphate (Hartmann Analytic, 0.5 GBq/mmol). For competition assays, transport was ini-
tiated in the presence of 20 mM compound (1000-fold excess). Transport was stopped after 0, 10,
20, 30, 45, 60, 150 s and, 5, 7.5 and 10 min incubation times with 200 ml ice-cold buffer and the sam-
ples were filtered and washed as above. Levels of radioactivity were measured by adding 200 ml
MicroScint-20 (Perkin Elmer) and measured with a TopCount scintillation counter (Perkin Elmer). Ini-
tial rates were determined from the linear part of the uptake curves.
Preparation of the mitochondrial compound library
To identify mitochondrial metabolites every enzyme in the KEGG metabolic database
(Kanehisa et al., 2017) was evaluated for mitochondrial localization using the MitoMiner database
of mitochondrial localization evidence (Smith and Robinson, 2016). A wide range of data were con-
sidered including large-scale experimental evidence from GFP tagging and mass-spectrometry of
mitochondrial fractions, mitochondrial targeting sequence predictions, immunofluorescent staining
from the Human Protein Atlas (Thul et al., 2017), and annotation from the Gene Ontology Consor-
tium (The Gene Ontology Consortium, 2017). Ensembl Compara allowed these data to be shared
across human, mouse, rat and yeast homologs (Zerbino et al., 2018). Once a list of enzymes with
probable mitochondrial localization was collated, KEGG was used to produce a corresponding list of
potential mitochondrial compounds. Additional candidates were taken from a computer model of
mitochondrial metabolism that manually partitioned metabolites on either side of the mitochondrial
inner membrane (Smith and Robinson, 2011). Compounds were dissolved in PIPES buffer (10 mM
PIPES pH 7.0, 50 mM NaCl) to a final concentration of 25 mM or in dimethyl sulfoxide to a final con-
centration of 100 mM. pH was adjusted if necessary and the stocks were frozen at  80˚C.
Analysis of the total number of identified transport protein substrates
in different species
The TransportDB database contains a large number of organisms for which the transporter comple-
ment has been identified via a bioinformatic pipeline, along with substrate predictions for the trans-
porters characterized (Elbourne et al., 2017). To acquire the figures in Supplementary file 1, a Perl
script driving an SQL query of the underlying MySQL database to TransportDB was developed to
quantify those transporters where no prediction could be made for the substrate for the listed spe-
cies. The number of transporters with unassigned specificity represents a minimal number, as the
search procedure uses sequence similarity to characterised transporters as a criterion. However, the
substrate specificity needs to be determined experimentally, as a single mutation in the binding site
can profoundly change substrate recognition.
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Thermostability shift assay and library screening
To determine stability, purified protein (typically 1–3 mg) was mixed with 20 mg/ml of the thiol-reac-
tive fluorophore 7-diethylamino-3-(4’-maleimidylphenyl) 4-methylcoumarin (CPM) and the fluores-
cent intensity was measured over a 25–90˚C range of temperature using a rotatory qPCR multi
sample instrument (Rotor-Gene Q, Qiagen, the Netherlands). Following an initial 18˚C pre-incuba-
tion step of 90 s, the temperature was ramped 1˚C every 15 s, with a 4 s wait between readings,
which is equal to a ramp rate of 5.6 ˚C/min. The excitation and emission wavelengths were 460 nm
and 510 nm, respectively. Five mg/ml stocks of CPM prepared in dimethyl sulfoxide were diluted to
0.1 mg/ml and equilibrated in assay buffer for 1 hr at room temperature in the dark before addition
to the protein sample. The assay buffer was usually the buffer in which the protein was purified or in
a similar buffer with a different pH (MES for pH 6.0, HEPES for pH 8.0) or a different concentration
of other ions. Data analyses and apparent melting temperatures (Tm, the inflection point of a melt-
ing temperature) were determined using software supplied with the instrument.
For GalP experiments, 500 mM sugar stocks were made in MilliQ water (Merck-Millipore, USA) as
10 times stocks. For Mhp1 experiments, 100 mM compound stocks were made in dimethyl sulfoxide
as 50 times stocks.
Data analyses and representation
Statistical analyses were performed using Microsoft Excel with the inbuilt function of two-tailed, two-
sample unequal variance Student’s t-test. The average apparent Tm of ‘no ligand’ control samples
(three technical repeats within each Rotor-Gene Q run) was subtracted from the apparent Tm mea-
sured for each compound addition in the same run. This assay was performed with three or five bio-
logical repeats using independent batches of purified protein. The null hypothesis of the t-test was
that the observed DTm for each compound was not significantly different from zero.
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